PRAX | tickerfilter.com

Fundamental analysis

41%

Profitability 35%

Dept financing 20%

Liquidity 50%

Performance 50%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-4.43%

1 Month

-2.76%

3 Months

20.37%

6 Months

676.19%

1 Year

758.08%

2 Year

485.36%

Key data

Stock price

$310.71

P/E Ratio

0.00

DAY RANGE

$303.01 - $316.46

EPS

-$13.88

52 WEEK RANGE

$26.70 - $356.00

52 WEEK CHANGE

$758.08

MARKET CAP

7.371 B

YIELD

N/A

SHARES OUTSTANDING

27.851 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

05-12-2025

BETA

2.14

PUBLIC FLOAT

AVERAGE 10 VOLUME

$363,266

AVERAGE 30 VOLUME

$400,794

Company detail

CEO: Marcio Souza
Region: US
Website: praxismedicines.com
Employees: 110
IPO year: 2020

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression.

PRAX - Praxis Precision Medicines Inc